Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
APSC Exit Exam Performance 2020–2023
Author(s): Jonathan Yap , Derek P Chew , Wael Almahmeed , et al Added: 1 year ago

Guidelines & Statements
John Sliberbauer
John Silberbauer is a Consultant Cardiologist and Electrophysiologist working at the Sussex Cardiac Centre in Brighton. He has a special interest in ventricular arrhythmia ablation and enjoys teaching and research within the field. He undertook a 2-year VT fellowship under the tutelage of Dr Paolo Della Bella in Milan and has pioneered the Coronary Vein Exit and CO2 Insufflation technique for… View more
Job title: Assistant Professor in Department III of Internal Medicine
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US. Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of… View more
TCT Middle East 25: Intracoronary Imaging
Author(s): Rania Hammami , Mognee Alameer , Mamas A Mamas Added: 1 year ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami, Dr Mognee Alameer and Prof Mamas Mamas as they discuss the evolving use of intracoronary imaging in contemporary practice.The experts examine imaging's expanding role across various clinical scenarios and its impact on intervention decision-making. Their insights cover modality selection considerations, safety profiles, cost… View more

Imaging & Diagnostics

Intervention
Dr Andrew Bullen is an endovascular and vascular surgeon at Wollongong Public Hospital, Australia. Dr Bullen completed his specialist medical training in Sydney after gaining experience nationally and internationally at several world-renowned vascular and trauma centres. He is an associate lecturer and examiner for the University of New South Wales, contributes to the surgical sciences… View more
Revolutionising Thrombosis Treatment in ACS, SSP and AF: Bridging the Gaps With Next Generation Anticoagulation Strategies
Author(s): Davide Capodanno , Sneha Shah Jain Added: 9 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more

Anticoagulation

Electrophysiology & Arrhythmia
John M Miller
John M. Miller, MD is aprofessor of Medicine and head of the Electrophysiology Service at Indiana University School of Medicine, has been active in research into mechanisms of arrhythmias and development of new mapping and ablation techniques for many years, including those pertaining to atrial fibrillation (AF). He was involved in some of the early work with Dr. Sanjiv Narayan in mapping of… View more
Sudden Cardiac Death Risk in Newly Diagnosed Heart Failure: SCD-PROTECT
Author(s): Marat Fudim , David Duncker Added: 3 months ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19… View more

Electrophysiology & Arrhythmia

Heart Failure
New Horizons in Dyslipidaemia 2026
Added: 4 months ago Source:  Radcliffe CVRM
Radcliffe Cardiology has announced New Horizons in Dyslipidaemia 2026, a live virtual event on 12 February 2026 (14:00–17:55 GMT) that will convene twelve international leaders to examine how lipid management is evolving, and where current practice continues to fall short.Despite the availability of highly effective lipid-lowering therapies, residual cardiovascular risk remains common. At the… View more

Guidelines & Statements

Prevention & Chronic Conditions